NOVAKA PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NOVAKA PHARMA
Largest movements
- Receivables within one year -€27,453
down €27,453 (-92.2%), from €29,763 to €2,310
of which Trade receivables: -€27,453
- Cash +€18,041
up €18,041 (+150%), from €12,035 to €30,076
mainly Other debts (+€46,271) and Net result for the year (+€31,857)
- Debts after one year -€64,193
down €64,193 (-8.5%), from €754,456 to €690,263
- Other debts +€46,271
up €46,271 (+34.0%), from €136,088 to €182,358
- Current portion of long-term debt -€33,254
down €33,254 (-21.6%), from €154,020 to €120,766
- Profit (loss) carried forward +€31,857
up €31,857 (+120%), from €26,472 to €58,329
- Gross operating margin -€39,407
down €39,407 (-25.2%), from €156,428 to €117,021
- Taxes +€11,295
up €11,295 (+759%), from €1,488 to €12,783
- Financial charges -€3,111
down €3,111 (-12.2%), from €25,432 to €22,321
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,120,942 | €1,100,386 | -€20,556 | -1.8% |
| Fixed assets | 21/28 | €1,075,851 | €1,066,554 | -€9,297 | -0.9% |
| Tangible fixed assets | 22/27 | €258,066 | €248,769 | -€9,297 | -3.6% |
| Land and buildings | 22 | €258,066 | €248,769 | -€9,297 | -3.6% |
| Financial fixed assets | 28 | €817,785 | €817,785 | = | 0.0% |
| Current assets | 29/58 | €45,091 | €33,832 | -€11,259 | -25.0% |
| Amounts receivable within one year | 40/41 | €29,763 | €2,310 | -€27,453 | -92.2% |
| Trade receivables | 40 | €27,453 | €0 | -€27,453 | -100% |
| Other amounts receivable | 41 | €2,310 | €2,310 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €12,035 | €30,076 | +€18,041 | +150% |
| Deferred charges and accrued income | 490/1 | €3,294 | €1,446 | -€1,848 | -56.1% |
| Total equity and liabilities | 10/49 | €1,120,942 | €1,100,386 | -€20,556 | -1.8% |
| Equity | 10/15 | €46,932 | €78,789 | +€31,857 | +67.9% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €26,472 | €58,329 | +€31,857 | +120% |
| Amounts payable | 17/49 | €1,074,010 | €1,021,597 | -€52,413 | -4.9% |
| Amounts payable after more than one year | 17 | €754,456 | €690,263 | -€64,193 | -8.5% |
| Financial debts | 170/4 | €754,456 | €690,263 | -€64,193 | -8.5% |
| Amounts payable within one year | 42/48 | €319,554 | €331,323 | +€11,769 | +3.7% |
| Current portion of amounts payable after more than one year | 42 | €154,020 | €120,766 | -€33,254 | -21.6% |
| Trade debts | 44 | €3,613 | €518 | -€3,095 | -85.7% |
| Suppliers | 440/4 | €3,613 | €518 | -€3,095 | -85.7% |
| Taxes, remuneration and social security | 45 | €25,834 | €27,681 | +€1,848 | +7.2% |
| Taxes | 450/3 | €17,124 | €18,772 | +€1,648 | +9.6% |
| Remuneration and social security | 454/9 | €8,709 | €8,909 | +€200 | +2.3% |
| Other amounts payable | 47/48 | €136,088 | €182,358 | +€46,271 | +34.0% |
| Accrued charges and deferred income | 492/3 | - | €11 | +€11 | |
| Non-recurring operating income | 76A | €0 | €1,183 | +€1,183 | |
| Remuneration, social security and pensions | 62 | €30,862 | €32,094 | +€1,232 | +4.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €9,270 | €9,297 | +€27 | +0.3% |
| Other operating charges | 640/8 | €7,202 | €8,464 | +€1,262 | +17.5% |
| Non-recurring operating charges | 66A | €10 | €206 | +€196 | +1,919% |
| Gross operating margin | 9900 | €156,428 | €117,021 | -€39,407 | -25.2% |
| Operating profit (loss) | 9901 | €109,084 | €66,961 | -€42,124 | -38.6% |
| Financial income | 75/76B | €0 | €0 | -€0 | -100% |
| Recurring financial income | 75 | €0 | €0 | -€0 | -100% |
| Financial charges | 65/66B | €25,432 | €22,321 | -€3,111 | -12.2% |
| Recurring financial charges | 65 | €25,432 | €22,321 | -€3,111 | -12.2% |
| Profit (loss) for the period before taxes | 9903 | €83,653 | €44,640 | -€39,013 | -46.6% |
| Income taxes | 67/77 | €1,488 | €12,783 | +€11,295 | +759% |
| Profit (loss) for the period | 9904 | €82,165 | €31,857 | -€50,308 | -61.2% |
| Profit (loss) for the period to be appropriated | 9905 | €82,165 | €31,857 | -€50,308 | -61.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.